# FDA WARNING_LETTER - Dr. Paul's Lab - February 09, 2021

Source: https://www.keypedia.com/records/warning_letter/dr-pauls-lab/ec911cb0-88cf-4846-bd98-a9666482b401

> FDA WARNING_LETTER for Dr. Paul's Lab on February 09, 2021. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: WARNING_LETTER
- Company Name: Dr. Paul's Lab
- Inspection Date: 2021-02-09
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research
- Summary: On February 16, 2021, the FDA and FTC issued a Warning Letter to Dr. Sarah's Essentials regarding the sale of "COVID-Aid Tincture." The agencies reviewed the company's websites, http://drpaulslab.net and https://drsarahsessentials.com, on January 28 and February 9, 2021.

The FDA determined that "COVID-Aid Tincture" is an unapproved new drug, sold in violation of section 505(a) of the FD&C Act, 21 U.S.C. § 355(a), and a misbranded drug under section 502 of the FD&C Act, 21 U.S.C. § 352. The product is marketed with claims to mitigate, prevent, treat, diagnose, or cure COVID-19, which is prohibited under sections 301(a) and (d) of the FD&C Act, 21 U.S.C. § 331(a) and (d).

The letter requires immediate action to cease the sale of all unapproved and unauthorized COVID-19 related products. Within 48 hours, the company must email COVID-19-Task-Force-CDER@fda.hhs.gov detailing corrective steps, including documentation and recurrence prevention. Failure to

## Related Officers

- [Director](https://www.keypedia.com/people/donald-d-ashley/060f0dda-e6e8-4f9c-97e7-f540d523d902)
- [Associate Director](https://www.keypedia.com/people/serena-viswanathan/7d1b292d-1f22-42ff-8452-0bc9673b8326)

Company: https://www.keypedia.com/companies/dr-pauls-lab/1e7b058f-a7c4-445f-86a3-7d6be9aa07ac

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c